Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference

Core Insights - Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel medicines for patients with rare and difficult-to-treat diseases [1][3] - The company will participate in Citi's 2025 Global Healthcare Conference on December 2, 2025, with a presentation scheduled for 1:00 PM ET [2] Company Overview - Catalyst Pharmaceuticals is committed to improving the lives of patients with rare diseases, emphasizing in-licensing, commercialization, and development of innovative therapies [3] - The company has a strong U.S. presence, which is central to its commercial strategy, while also exploring opportunities for global expansion [3] - Catalyst has been recognized on the Forbes 2025 list as one of America's Most Successful Mid-Cap Companies and on the 2024 Deloitte Technology Fast 500™ list as one of North America's Fastest-Growing Companies [3]